HOME › DRUGS › NATALIZUMAB-SZTN
ACTIVE SUBSTANCE / INN

NATALIZUMAB-SZTN

Brand name(s): TYRUKO
FDA LISTED
PRESCRIPTION
BLA761322
ACTIVE SUBSTANCE
Natalizumab-Sztn
REGULATORS
FDA
SPONSORS / MAH
SANDOZ INC
TOTAL APPLICATIONS
1
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
TYRUKOBLA761322SANDOZ INCPrescription

FULL INTELLIGENCE ON NATALIZUMAB-SZTN

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →